Multivariate Cox regression analysis of baseline variables adversely affecting PFS and OS
| Variables . | HR (95% CI) . | P . |
|---|---|---|
| PFS | ||
| EMD | 5.28 (1.43-19.53) | .013 |
| SUV > 4.2 | 2.13 (1.10-4.12) | .024 |
| ISS stage II-III | 2.12 (1.13-3.98) | .020 |
| del(17p) ± t(4;14) | 2.00 (1.03-3.88) | .040 |
| OS | ||
| EMD | 9.75 (3.44-27.65) | .000 |
| SUV > 4.2 | 3.23 (1.35-7.72) | .008 |
| Variables . | HR (95% CI) . | P . |
|---|---|---|
| PFS | ||
| EMD | 5.28 (1.43-19.53) | .013 |
| SUV > 4.2 | 2.13 (1.10-4.12) | .024 |
| ISS stage II-III | 2.12 (1.13-3.98) | .020 |
| del(17p) ± t(4;14) | 2.00 (1.03-3.88) | .040 |
| OS | ||
| EMD | 9.75 (3.44-27.65) | .000 |
| SUV > 4.2 | 3.23 (1.35-7.72) | .008 |
PFS indicates progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; SUV, standardized uptake value; EMD, extramedullary disease; del, deletion; t, translocation; and ISS, international staging system.